FDA Inspection 993733 — Fresenius Kabi iPSUM Srl
The FDA completed an inspection of Fresenius Kabi iPSUM Srl on November 17, 2016 in Villadose. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 17, 2016
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Villadose (Italy)